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Since early descriptions of DCs as primary stim-
ulators of adaptive immunity (Steinman, 1991), 
their role in establishing and regulating immune 
responses has been central to diverse immuno-
logical fields such as transplantation (Larsen et al., 
1990; Hill et al., 2011), autoimmunity (Llanos 
et al., 2011), infectious disease (Poudrier et al., 
2012), and vaccinology (Arnason and Avigan, 
2012). As critical mediators of antigen presenta-
tion, significant effort has been spent describing 
activation of conventional DCs (cDCs) in pe-
ripheral tissue (Moodycliffe et al., 1994; Austyn, 
1996; Rescigno et al., 1997) and characterization 
of their subsequent migration to secondary lym-
phoid organs (Itano et al., 2003; Randolph et al., 
2005; Alvarez et al., 2008; Braun et al., 2011; Tal 
et al., 2011). Once in peripheral LNs, migratory 
DC (mDC) populations from the injection site 
present antigen to cognate T and B cells and 
stimulate adaptive immunity (Qi et al., 2006).
The activation and maturation of mDCs is 
thought to follow a three-stage process. First, im-
mature DCs encounter antigen in the periph-
ery, leading to up-regulation of MHC class II and 
co-stimulatory molecules with a concomitant 
reduction in phagocytic capacity (Rescigno 
et al., 1997). Second, antigen-loaded DCs ac-
quire migratory capacity through the expression 
of matrix metalloproteases (Yen et al., 2008), mi-
gratory adhesion molecules (Acton et al., 2012), 
and rapid actin treadmilling to enter and migrate 
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Dendritic cells (DCs) are well established as potent antigen-presenting cells critical to 
adaptive immunity. In vaccination approaches, appropriately stimulating lymph node–
resident DCs (LNDCs) is highly relevant to effective immunization. Although LNDCs have 
been implicated in immune response, their ability to directly drive effective immunity to 
lymph-borne antigen remains unclear. Using an inactive influenza vaccine model and whole 
node imaging approaches, we observed surprising responsiveness of LNDC populations to 
vaccine arrival resulting in a transnodal repositioning into specific antigen collection sites 
within minutes after immunization. Once there, LNDCs acquired viral antigen and initiated 
activation of viral specific CD4+ T cells, resulting in germinal center formation and B cell 
memory in the absence of skin migratory DCs. Together, these results demonstrate an 
unexpected stimulatory role for LNDCs where they are capable of rapidly locating viral 
antigen, driving early activation of T cell populations, and independently establishing 
functional immune response.
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Noncommercial–Share Alike–No Mirror Sites license for the first six months 
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2008; Sung et al., 2012; Kastenmüller et al., 2013) were im-
munized s.c. in the footpad with UV-inactivated influenza A 
virus strain PR8 (UV-PR8). DCs were tracked by multipho-
ton intravital microscopy (MP-IVM) of the popliteal LN (PLN) 
by surgically exposing the node in live, anesthetized mice 
(Gonzalez et al., 2010). Continuous imaging for 40 min after 
UV-PR8 vaccination revealed an influx of LNDCs proxi-
mal to the collagen capsule (<150 µm; Fig. 1 a and Video 1). 
Quantitation of cellular trafficking over this period identified 
a three- to fourfold increase in the number of YFP+ DCs 
within this region (3.23 ± 0.24; P < 0.001), suggesting a rapid 
repositioning to the periphery of the PLN.
In addition to increased cell number within the LN pe-
riphery, LNDCs exhibited extensive morphological changes 
over the 40-min imaging period (Fig. 1 a, inset). Measured in 
bulk, DCs within these regions increased in surface area by 
almost 50% after vaccination and experienced a concomitant 
increase in volume and decrease in spherical index, a measure 
of the spherical nature of an object (Fig. 1 c and not depicted). 
Importantly, the fluorescence intensity of individual DCs did 
not change over this time period, indicating that the observed 
phenotypic changes were not caused by changes in YFP ex-
pression. Together, these data suggest an unexpected accumu-
lation and activation of resident DCs in the PLN periphery 
immediately after vaccination.
Repositioning of LNDCs to the medulla
To address the origin of the accumulating DCs, in vivo cellu-
lar tracking was applied to the live imaging model. By track-
ing individual DCs, it was observed that rather than infiltrating 
from an outside source, the cells originated from the interior 
of the PLN (>150 µm from the collagen capsule), which is 
beyond the imaging depth threshold for our imaging system 
(Fig. 1 b and Video 1). Pretreatment of mice with CD62L 
blocking antibody or local administration of Pertussis toxin, 
two approaches which limit influx of leukocytes from the vas-
culature or lymphatics, had negligible effects on DC accumu-
lation (not depicted). These results provide additional evidence 
that the activated DCs originated within the PLN before vac-
cination and confirmed their identity as LNDCs.
To assess the overall movement of LNDCs after vaccina-
tion, 50-µm serial cryosections of PLNs were imaged by mul-
tiphoton microscopy (MPM) and serially reconstructed for 
analysis of whole PLNs. Similar approaches were reported by 
Grigorova et al. (2010) using confocal microscopy for partial 
PLN imaging. By in vivo labeling medullary macrophages 
through preinjection of an -F4/80 mAb into the footpad of 
CD11c-eYFP reporter mice, the medulla could be outlined and 
shown to include relatively sparse populations of LNDCs in 
resting naive LNs (Fig. 1 d). In agreement with the live imag-
ing data, injection of UV-PR8 into the footpad of CD11c-
eYFP mice stimulated a visible shift of the LNDC population 
into the medullary compartment by 60 min after vaccination 
(Fig. 1 d). Flow cytometric analysis of single cell suspensions 
of PLN indicated no appreciable increase of LNDCs at these 
time points. This global repositioning of the LNDCs can be 
along lymphatic vessels (Lämmermann et al., 2008). Finally, LN-
bound mDCs cross the subcapsular sinus floor into the paracorti-
cal region and interact with cognate T cells and LN-resident 
DCs (LNDCs) within the draining LN (Allan et al., 2006; Braun 
et al., 2011) to establish protective downstream immunity.
After antigen capture in peripheral tissues, the activation 
and migration of mDCs into draining LNs is delayed for up 
to 18–24 h to allow for transcriptional and translational mod-
ification and a crawling migration sometimes representing dis-
tances of thousands of cell body lengths of the mDC. In the 
case of vaccination, however, arrival of injected antigen is rapid, 
with detectable antigen arriving in the draining LN via the 
afferent lymphatics within minutes (Roozendaal et al., 2009; 
Gonzalez et al., 2010). This timing discrepancy between antigen 
arrival in the LN and the migration of DCs from the periph-
ery leaves open a potential window whereby targeting a vaccine 
to a nondegradative, immunostimulatory compartment within 
the LN could have important humoral immune ramifications.
Several studies have focused on the drainage of lymph-borne 
antigen from the afferent lymph into the subcapsular sinus of 
the draining LN (Szakal et al., 1983; Carrasco and Batista, 2007; 
Junt et al., 2007; Phan et al., 2007; Roozendaal et al., 2009; 
Gonzalez et al., 2010). A current view is that subcapsular sinus 
macrophages rapidly capture antigen from the lymph and par-
ticipate in its active transport to the B cell follicle. Less well 
described is the downstream filtration of the lymph within the 
medulla by medullary sinus-lining macrophages (Gray and 
Cyster, 2012) and LNDCs (Gonzalez et al., 2010). Historically, 
DCs residing in the LN (LNDCs) have been described as rela-
tively sessile at steady-state, (Steinman et al., 1997; Lindquist et al., 
2004) and insufficient to drive effective immunity after direct 
antigen acquisition (Itano et al., 2003; Allenspach et al., 2008). 
However, the recent observation of direct viral capture in the me-
dulla by the LNDC population suggested they may have a more 
active role in the establishment of downstream immune response 
in the case of influenza vaccination (Gonzalez et al., 2010).
To extend our understanding of the role of LNDCs in es-
tablishing immune response to influenza vaccination, resident 
DCs were characterized at a whole-LN level. Unexpectedly, 
a major trans-nodal repositioning of LNDCs from the T cell 
cortex to the afferent medulla was observed within minutes 
of viral antigen arrival from the afferent lymphatics, areas re-
cently shown to be important in vaccine efficacy (Liu et al., 
2014). This migration leads to rapid viral acquisition by 
LNDCs and stimulation of viral-specific naive CD4+ T cells. 
Furthermore, total elimination of skin mDCs had a negligible 
effect on the generation of a protective humoral response in 
mice vaccinated with UV-inactive virus. Collectively, the re-
sults suggest a model in which LNDCs are fully competent in 
establishing robust, long-term viral immunity, even in the ab-
sence of mDCs from the injection site.
RESULTS
Activation of LNDCs after influenza vaccination
To characterize LNDC response after vaccination, CD11c-
eYFP C57BL/6 mice (Lindquist et al., 2004; Hickman et al., 
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study by Hickman et al. (2008) suggested a primary role for 
these sites in priming CD8 T cell immunity.
We hypothesized that these sites may serve as destinations 
for migrating LNDCs. To characterize the architectural iden-
tity of the IFRs, PLNs were in vivo labeled with antibodies 
against the lymphatic endothelium (a-Lyve-1) and subcapsu-
lar sinus macrophages (a-CD169) and then optically cleared 
for MP imaging. Projections of whole nodes after optical 
clearing (Ertürk et al., 2012) identified long extensions of the 
medulla that protruded extensively between B cell follicles 
and merged with the subcapsular sinus (Video 3). This obser-
vation identified two different types of IFR structure: cortical 
IFRs (cIFRs), which represent chemokine boundaries be-
tween the paracortex and B cell follicles, and medullary IFRs 
(mIFRs), which represent the most afferent connection points 
between the medulla and the subcapsular sinus (Fig. 2 a). In-
terestingly, these regions have recently been targeted by Liu 
et al. (2014) in vaccination attempts, resulting in greatly en-
hanced T cell priming. Confocal imaging of mIFRs in PBS or 
UV-PR8–vaccinated PLNs identified YFP+ clusters similar to 
those identified in reconstruction analysis, identifying these 
sites as destinations for migrating LNDCs (Fig. 2 b). Histologi-
cal staining confirmed that both CD11bhi and CD8a+ LNDC 
quantified through a shift in the ratio of medulla-occupying 
versus total LNDCs (Fig. 1 e). Migration data were further 
verified through MP-IVM, through which the rapid arrival 
of LNDCs into the medulla could be observed (Video 2). 
Surprisingly, this change in both LNDC morphology and lo-
calization could not be identified after the injection of tradi-
tional adjuvants such as alum and MF59 despite extensive 
inflammation of the PLN, suggesting that this response may 
be specific toward viral antigen or endosomal TLR signaling.
Capture of viral antigen by LNDCs  
within interfollicular regions (IFRs)
Recent studies have identified interactions of DCs and T cells 
outside of the T cell area within IFRs in the stimulation of 
memory CD8+ T cell responses (Hickman et al., 2008; León 
et al., 2012; Sung et al., 2012). In these studies, central mem-
ory T cells were generated after viral infection with the pur-
pose of tracking those cells in the LN after secondary challenge. 
Although there is debate on the resting location within the 
LN, it is clear that after secondary challenge, central memory 
CD8+ T cells are rapidly recruited to the IFRs where they 
undergo activation by antigen-loaded APCs. Furthermore, a 
Figure 1. LNDCs migrate to the medulla after influenza vaccination. (a) MP-IVM of DC arrival in the PLN periphery after UV-PR8 vaccination. 
Snapshots were taken at 0 and 36 min after injection and are representative of three independent surgeries (three mice) from different imaging sessions. 
(inset) High magnification of two individual LNDCs. (b, left) Real-time tracking of LNDCs from panel a. LNDC tracks are highlighted (white) and final desti-
nations marked (closed circles). (right) Vector representation of complete tracks. Green and red vectors represent LNDCs with migration paths toward or 
away from the PLN capsule, respectively. Data are representative of three independent surgeries (three mice) from different imaging sessions. (c) Quanti-
tation of bulk DCs from live imaging in panel a. DC spherical index (red) and surface area (black) are displayed. ANOVA (black), P < 0.005; ANOVA (red),  
P < 0.005. (d) Fluorescent reconstructions of in vivo–labeled CD11c-eYFP reporter PLNs. PLNs were collected at 60 min after PBS or UV-PR8 vaccination. 
Data are representative of three reconstructed PLNs. B, follicles; M, medulla; MM, medullary macrophage; T, T cell cortex. (e) Quantitation of the percent-
age of LNDCs inside or outside of the medulla as in d (n = 3 PLNs). *, P < 0.05. Mean ± SEM.
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LNDCs present viral antigen to CD4+ T cells near IFRs
Previous work by Itano et al. (2003) interrogated the role of 
mDCs versus LNDCs in CD4+ T cell stimulation. In that study, 
soluble peptide designed for presentation on MHC II was in-
jected s.c., and downstream T cell responses were tracked in 
the draining LN. The authors observed two waves of peptide 
presentation, one at 6 h, which resulted in only transitory ac-
tivation, and one at 18 h, which stimulated a more robust, long-
term T cell response. The authors concluded that although 
resident DCs can activate T cells, the resident cells induce 
only a limited response with mDCs from the injection site 
required for robust immunity. To determine whether LNDCs 
participate in activation of viral-specific CD4+ T cells within 
this study, CD11c-eYFP mice were adoptively transferred with 
labeled, ova-specific CD4+ OT-II T cells 24 h before vaccina-
tion with a UV-inactive recombinant strain of PR8 (UV-PR8-
OTII), which was engineered to express the OT-II epitope 
(Thomas et al., 2006).
As predicted, vaccination with UV-PR8-OTII stimulated 
activation of cognate T cells within 6 h, as indicated by CD69 
up-regulation (Fig. 3 a). Although individual DC–T cell con-
tacts could be observed as early as 6 h, extensive interaction 
between LNDCs and CD4+ OT-II T cells was observed near 
IFRs by 12 h after vaccination (Fig. 3 b). Additionally, small 
populations had accumulated in mIFRs within 60 min of 
vaccination, suggesting a multisubset responsiveness to inacti-
vated influenza (Fig. 2 b).
Afferent lymph flowing through the medullary sinus is 
constitutively filtered by sinus-lining macrophages (Gray and 
Cyster, 2012), and this process predicts a natural gradient of 
viral antigen after vaccination. Thus, it is proposed that the 
highest antigen concentrations would reside at the tips of 
these mIFRs (Video 4). To test this possibility, mice were in-
jected s.c. with UV-PR8 labeled with Alexa Fluor 633. Fluor-
escent PLN reconstructions at various time points identified 
accumulation of viral antigen within mIFRs over 6 h after 
vaccination (Fig. 2 c). In contrast, lower levels of virus were 
retained in the subcapsular sinus and the deeper medullary 
compartments connecting with the efferent lymphatics. It 
was hypothesized that these antigen-rich regions might serve 
as a destination for migrating LNDCs. High-resolution imag-
ing of IFRs bearing dense deposits of viral antigen showed 
large numbers of infiltrating LNDCs within 60 min of viral 
arrival at the node. Analysis of LNDCs by flow cytometry 
confirmed viral capture by both CD11bhi and CD8a+ LNDCs 
within 30 min after injection (Fig. 2 e), which was verified by 
MPM identifying viral patches on the surface of LNDCs at 
later time points (Fig. 2 f, inset).
Figure 2. LNDCs infiltrate mIFRs and acquire viral antigen. (a) Schematic diagram of the architecture of a PLN. mIFRs and cIFRs are highlighted in red and 
blue, respectively. (b) Confocal imaging of mIFRs in CD11c-eYFP PLNs 40 min after vaccination with PBS or UV-PR8. Blue arrowheads: CD8a+ DCs; red arrowheads:  
CD11bhi DCs. Images are representative of three independent trials; three mice/trial. B, follicles; M, medulla; T, T cell cortex. (c) Reconstructions of in vivo–labeled 
C57BL/6 PLNs vaccinated with A633–UV-PR8 and collected at 0.5 or 6 h after injection. White arrowheads: IFRs. SS, subcapsular sinus. Images are representative 
of three independent experiments; two mice per time point per experiment. (d) MPM of in vivo–labeled CD11c-eYFP PLNs 60 min after PBS or A633–UV-PR8 
vaccination. Dashed lines: IFRs. Images are representative of four independent experiments; two mice per experiment. (e) LNDC capture of A488–UV-PR8 by  
flow cytometry 60 min after injection. (left) Cells displayed are pregated to be CD11chi (n = 4 PLNs). Mean ± SEM. (f) MPM of in vivo–labeled CD11c-eYFP 
PLNs 6 h after A633–UV-PR8 vaccination. White arrowhead: UV-PR8 patch on the LNDC. Image is representative of four independent experiments; two  
mice per experiment.
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clusters of viral-specific T cells could be identified surround-
ing LNDCs in these regions. To quantitate clustering, labeled, 
naive OT-II T cells were transferred into CD11c-eYFP re-
cipients, which were subsequently vaccinated with UV-PR8-
OTII 12 h before LN harvesting. The LNs were serially imaged 
for reconstruction, and single plane images were captured from 
each reconstruction, representing 400 µm of vaccinated ver-
sus control LNs. Using histocytometric analysis (Gerner et al., 
2012), OT-II T cells were identified within each plane, and 
each T cell was assessed for the number of T cell “neighbors” 
present in the image within one T cell diameter. The resulting 
measure of T cell clustering revealed significant increases in 
the mean number of  T  cell neighbors and increases in the 
absolute number of T cells with multiple neighbors within 
vaccinated versus nonvaccinated LNs (Fig. 3 c). Significantly, 
heat mapping the number of T cell neighbors onto the ori-
ginal images identified the border between the paracortex 
and IFRs as the most densely populated by clustered T cells 
(Fig. 3 d). Analysis of T cell migration at 24 h after immunization 
identified discreet clusters at the extremes of the paracortex, 
with specific colocalization of T cell clusters at the mIFR–
cortical junctions (Fig. 3, e and f).
Clustering of viral-specific CD4 T cells is chemokine dependent
Previously mentioned studies describing central memory 
CD8 T cell responses within cIFRs have suggested the che-
mokine CXCR3 as a critical mediator of cellular retention in 
these regions. The ligands for CXCR3, CXCL9 and CXCL10, 
are produced by both hematopoietic and stromal cells in re-
sponse to viral challenge and are critical to CD8 T cell re-
cruitment to these sites (Sung et al., 2012; Kastenmüller et al., 
2013). Additionally, Groom et al. (2012) have recently de-
scribed the up-regulation of CXCR3 as an early first step in 
the generation of robust Th1 CD4 T cell responses. Thus, we 
hypothesized that the clustering of CD4+ OT-II T cells with 
LNDCs and virus in the IFR after immunization with UV-
PR8-OTII could be CXCR3 dependent. To examine whether 
CD4+ OT-II T cells become activated and differentiate to 
CXCR3+ T cells, LNs were harvested from immunized mice, 
and CD4+ T cells were analyzed by flow cytometry for ex-
pression of cell surface markers of activation. Notably, an in-
crease in CD69 expression on CD4+ OT-II T cells was observed, 
followed by a corresponding increase in CD44 (Fig. 4 a and 
not depicted). By gating on newly activated CD69+ cells, in-
creases in CXCR3 expression could be identified as early as 
12 h after vaccination and continued to increase over several 
days (Fig. 4, a and b).
As recent reporting has shown that activated DCs arriv-
ing from the periphery express CXCL10 and that direct 
injection of LPS/Poly I:C can induce CXCL10 expression 
within 12 h in the draining LN (Groom et al., 2012), it was 
predicted that LNDCs might express this chemokine after im-
munization with UV-PR8-OTII. Thus, the release of CXCL10 
by activated LNDCs within the IFR could explain the extensive 
clustering of CD4+ T cells observed within the antigen-rich 
IFRs. To test this possibility, CXCL9/10 reporter mice (REX3; 
Figure 3. Cognate CD4+ T cells relocate to mIFRs after vaccina-
tion. (a) C57BL/6 mice received naive OT-II T cells and were vaccinated 
with UV-PR8-OTII. OT-II T cell activation in PLNs was analyzed by flow 
cytometry (n = 4 mice). *, P < 0.05; ***, P < 0.001. Mean ± SEM. (b) CD11c-
eYFP mice received labeled naive OT-II T cells and were vaccinated 
with UV-PR8-OTII. MPM of a PLN 12 h after vaccination. White arrowheads: 
LNDC/OT-II contacts. Images are representative of three PLNs; two 
independent trials. (c) OT-II neighbor analysis of PLNs as shown in b. 
Each symbol type represents an individual PLN, with four XY planes 
shown. **, P < 0.005. Horizontal bars indicate mean. (d) Heat map of 
OT-II neighbor counts as shown in c. OT-II cells were identified from 
images (left) and displayed with color indicative of the number of 
corresponding OT-II neighbors (right). B, follicles; M, medulla; T,  
T cell cortex. (e) CD11c-eYFP recipients received labeled naive OT-II T cells 
and were vaccinated with UV-PR8-OTII. Fluorescent reconstruction of 
a PLN 24 h after vaccination is shown. Per, PLN “periphery.” Image is rep-
resentative of three independent trials; two mice/trial. (f) C57BL/6 mice 
received OT-II T cells and were vaccinated with UV-PR8-OTII. PLNs were 
collected at 24 h after vaccination, optically cleared, and imaged. Data are 
represented with medulla isosurfacing to aid visual interpretation. White 
arrowheads: mIFR/T cell cluster colocalization. Image is representative 
of two trials; two mice/trial.
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Groom et al., 2012) were vaccinated with UV-PR8, and LNs 
were harvested after 24 h for analysis by flow cytometry and 
immunohistochemistry. Flow analysis identified the expres-
sion of CXCL10 by both CD11bhi and CD8a+ LNDCs after 
vaccination (Fig. 4 c), although the CD11bhi population ap-
peared more robustly responsive. Fluorescent reconstructions 
of vaccinated REX3 PLNs identified high CXCL10 expres-
sion on dendritic-looking cells within mIFRs after vaccina-
tion, suggesting LNDC expression (Fig. 4 d). Confocal analysis 
positively identified these cells as DCs through CD11c ex-
pression and confirmed clustering of CXCL10-positive DCs 
within IFRs by 24 h after vaccination (Fig. 4 e). The timing 
of this event corresponded with both LNDC migration and 
formation of T cell clusters.
To confirm the importance of CXCL10 in attracting viral-
specific T cells to the IFRs, mice were adoptively transferred 
with differentially labeled CXCR3+/+ and CXCR3/ OT-II 
T cells and subsequently immunized with UV-PR8-OTII virus. 
Characterization of the vaccinated recipients revealed a sig-
nificant defect in the clustering of CXCR3/ OT-II cells at 
24 h after vaccination, confirming the importance of CXCR3 
in T cell migration (Fig. 4 f). Additionally, flow cytometric 
analysis of CXCR3/ OT-II T cells displayed a profound 
deficiency in both CD69 activation and CD40L expression 
(Fig. 4, g and h). These results replicate the study by Groom 
et al. (2012), which described early activation defects, fol-
lowed by a deficient Th1 response in the absence of CXCR3. 
Together, these data suggest a model whereby LNDC activa-
tion of CD4+ T cells at early time points leads to expression of 
CXCR3 and contributes to the efficient localization of cog-
nate cells into mIFRs, resulting in efficient early activation.
LNDC-dependent T cell activation
Although the activation of T cells within 6 h of vaccina-
tion suggested a role for LNDCs in early activation of CD4+ 
T cell responses to UV-PR8, it remained unclear whether 
skin-resident mDCs were required to establish an enduring hu-
moral response. Using a system developed by Itano et al. (2003), 
the contribution of the mDC population could be effectively 
removed through resection of the injection site within 30 min 
after immunization (Kissenpfennig et al., 2005). By adminis-
tering UV-PR8 intradermally in the ear and removing the ear 
shortly after administration, the relative contribution of mDC 
and LNDC populations could be evaluated in the auricular 
LN (ALN).
Figure 4. CXCR3-dependent clustering of viral-specific CD4+  
T cells in mIFRs. (a) Flow cytometry of OT-II T cell activation after UV-
PR8-OTII vaccination at the indicated time points (n = 4). (b) Expression 
of CD69 (black) and CXCR3 (red) by OT-II T cells at the indicated time 
points as in panel a. CD69+ OT-II cells were gated for CXCR3 expression 
analysis. Symbols represent individual mice. ANOVA (CD69), P < 0.0005; 
ANOVA (CXCR3), P < 0.005 (n = 4). Mean ± SEM. (c) CXCL10 expression 
in vaccinated REX3 mice or unvaccinated REX3 controls by flow cytom-
etry. (left) Displayed cells gated on CD11chi cDCs, followed by CD11bhi or 
CD8a+ as indicated. (right) Percentage of CXCL10-positive DCs by subset 
after vaccination (n = 4). ***, P < 0.001. Horizontal bars indicate mean. 
(d) MP imaging of REX3 PLN 24 h after UV-PR8 vaccination. Dashed 
line: medulla (M). B, follicles; T, T cell cortex. Images are representative 
of four PLNs from two independent trials. (e) Confocal imaging of REX3 
PLN 24 h after UV-PR8 vaccination. Arrowheads: CXCL10-positive DCs. 
Images are representative of four PLNs; two independent trials. (f) C57BL/6 
recipients received differentially labeled WT or CXCR3-deficient naive 
OT-II T cells. Recipients were vaccinated with UV-PR8-OTII, and PLNs 
were collected at 24 h. Quantitation of clustering efficiency of WT or 
CXCR3-deficient OT-II T cells is shown (n = 5). (g and h) Adoptive trans-
fers were performed as in f. Recipients were vaccinated, and PLN  
suspensions were collected 60 h after vaccination for flow analysis. 
Individual T cell populations were compared with the same population 
in unvaccinated contralateral controls. CD40L (g) and CD69 (h) acquisi-
tion is expressed as fold change (FC) in vaccinated versus unvaccinated 
population controls (n = 5). **, P < 0.005; ***, P < 0.001.
 
JEM Vol. 211, No. 8 
Article
1617
in the vG group, providing additional evidence for LNDC/
mDC collaboration in a vaccination setting. Altogether, these 
data demonstrate that LNDCs are capable of stimulating 
CD4+ Th1-dependent protective humoral responses to influ-
enza vaccination.
DISCUSSION
An earlier study identifying capture of lymph-borne inactive 
influenza virus by LNDCs raised the question of the relative 
importance of this population in overall humoral immunity 
(Gonzalez et al., 2010). To gain a broader understanding of 
LNDCs in response to vaccination with inactive influenza, 
a whole-node imaging approach was developed, and mice 
bearing a fluorescent reporter for DCs (CD11c+) were vacci-
nated with UV-PR8. After s.c. vaccination, viral antigen was 
observed within the draining LN within minutes, as expected. 
Surprisingly, however, the virus accumulated over the first 6 h 
within specialized sites identified as mIFRs.
Using this approach, C57BL/6 mice were vaccinated with 
PBS or UV-PR8 intradermally, with half of the vaccinated 
group undergoing ear removal (here referred to as the van Gogh 
[vG] group) within 30 min after vaccine administration. Using 
REX3 reporter mice, expression of CXCL10 by both CD11bhi 
and CD8a+ in WT or vG-vaccinated animals was assessed 24 h 
after injection/resection. Interestingly, although CXCL10 ex-
pression was still robust in both LNDC populations, suggesting 
normal responsiveness to vaccination despite a lack of mDCs 
in the vG group (Fig. 5 a), there was a small decrease in expres-
sion by the CD8a+ subset, perhaps relating to its known reliance 
on incoming mDCs from the periphery (Allan et al., 2006).
By transferring CFSE-labeled naive OT-II T cells into B6 
recipients and using the vG vaccination system, potential de-
ficiencies in T cell proliferation and activation could be assessed 
in the absence of mDCs from the injection site. Surprisingly, 
vG group OT-II T cells proliferated similarly to the WT group 
(Fig. 5 b) and could be tracked through seven divisions in 60 h. 
Tracking T cell activation by division status, cells could be 
observed acquiring both CXCR3 and CD40L as they prolif-
erated in both the WT and vG groups (Fig. 5, c and d). Inter-
estingly, although CD40L expression appeared identical in 
both groups, there was a slight delay in CXCR3 acquisition 
between the WT and vG group. These findings may also sug-
gest collaboration with mDCs in reinforcing Th1 immunity 
development as they arrive from the periphery.
LNDC-dependent B cell memory
As LNDC and T cell activation appeared to be intact despite 
the absence of mDCs in the vG model, it was hypothesized 
that LNDCs may be sufficient to drive downstream protective 
humoral immunity despite the absence of mDCs. To test this 
hypothesis, the vG vaccination model was used in C57BL/6 
mice alongside PBS-vaccinated controls. ALNs were collected 
at day 7 after vaccination, and germinal center staining appeared 
normal in both WT and vG groups, confirming effective T cell 
help despite the absence of mDCs (Fig. 6 a). Antibody titers 
collected at day 10 after vaccination showed normal increases 
in IgM, IgG1, and IgG2b in vG versus WT vaccination groups 
in comparison with unvaccinated controls, suggesting normal 
class switching and germinal center development (Fig. 6 b).
To test the functionality of this antibody response, vacci-
nated, or unvaccinated controls were challenged intratrache-
ally with a lethal dose of live PR8 on day 21 after vaccination. 
Morbidity was monitored for 9 d after infection, at which point 
the unvaccinated control group was sacrificed as a result of 
excessive weight loss. Neither WT nor vG groups experienced 
significant weight loss over the course of infection, indicating 
protective immunity had been generated with or without mDC 
arrival from the injection site (Fig. 6, c and d). Finally, antibody 
titers were assessed at day 9 and compared with both unvacci-
nated and uninfected controls. As expected, antibody titers 
showed extensive class switching in both WT and vG groups, 
and protective IgG2b responses were identical between groups. 
It is worth noting that although not required for protection, 
IgG1 antibody titers were slightly, but insignificantly decreased 
Figure 5. mDC-independent LNDC/CD4+ T cell activation. Ear re-
section in the vG model 30 min after vaccination. (a) Percentage of CD8a+ 
or CD11bhi cDCs in the ALN 24 h after ear vaccination. PBS, WT, and vG 
groups are displayed. ANOVA (light gray), P < 0.0001; ANOVA (dark gray), 
P < 0.0001 (n = 4). *, P < 0.05; ***, P < 0.001. (b) CFSE-labeled OT-II T cells 
were transferred into C57BL/6 recipients. Recipients were vaccinated in 
the ear and separated into WT and vG groups. ALNs were isolated at 60 h 
after injection and analyzed by flow cytometry. (left) Percentage of OT-II  
T cells by division number as assessed by CFSE dilution. ANOVA, P > 0.1. 
(right) Representative plot of CFSE dilution in WT and vG groups (n = 4 
mice/group). (c and d) Adoptive transfers were established as in c. OT-II  
T cell expression (MFI) of CXCR3 (c) and CD40L (d) was assessed by T cell 
division to track acquisition over time. (c) Two-way ANOVA, P < 0.0001 
overall, P < 0.05 between groups. (d) Two-way ANOVA, P < 0.0001 overall, 
P > 0.1 between groups (n = 4 mice/group). Mean ± SEM.
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T cells that became activated based on expression of CD69, 
CD44, and CXCR3. Thus, three lines of evidence are presented 
that support a role for LNDCs in promoting a humoral re-
sponse to inactive PR8 independent of mDCs: (1) activation 
of viral-specific CD4+ T cells before expected arrival of skin 
mDCs, (2) activation of viral-specific CD4+ T cells within 
PLNs in the absence of mDCs, and (3) a normal humoral mem-
ory response despite surgical removal of the injection site 
within 30 min of vaccination. Notably, although these find-
ings clearly demonstrate sufficiency of the resident DC popu-
lation in establishing humoral immunity, they do not address 
the requirement of mDCs under conditions where lymph-
borne antigen is not readily available.
Although several groups have previously described resi-
dent DC populations in skin-draining LNs (Lindquist et al., 
2004), few have directly assessed their potential in presenting 
antigen acquired directly from the lymph. In one study, Itano 
et al. (2003) describe a two-step process of antigen presentation 
where resident DCs in the LN were capable of acquisition and 
presentation of soluble peptides, but skin-resident mDCs were 
required for effective immunity. In another study, Allenspach 
et al. (2008) found that in the case of soluble peptide adminis-
tered with CFA, resident DCs were similarly deficient in T cell 
presentation. Our findings are not inconsistent with these 
results, as the robust activation/migration of resident DCs 
cannot be identified after traditional adjuvant administration 
(alum or MF59). The profound differences in these responses 
also raise interesting questions about a potential gap between 
traditional vaccination approaches and natural response to viral 
antigen. As medullary macrophages rapidly degrade protein 
antigen as a part of normal lymphatic filtration, it is important 
to understand how to maximize antigen exposure to efficient 
antigen presenters, especially when antigen concentration is 
highest immediately after vaccination. Data from this study 
suggest that LNDCs are capable of effectively using antigen 
when appropriately stimulated and could represent an effi-
cient target for vaccination approaches.
An unexpected observation was the rapid kinetics of LNDC 
repositioning from the paracortical region to the mIFR in re-
sponse to localization of viral antigen. Although large deposits 
of LNDCs were observed in viral-loaded IFRs within hours 
of vaccination, individual LNDC morphological changes 
could be observed within 12 min of vaccination. The highly 
directional migration pattern of LNDCs to the sites of viral 
accumulation suggests a response to chemotactic mediators 
released from a prestored source after innate sensing of viral 
antigen, although this source remains yet unclear.
A recent study has identified CXCR3 and its ligands 
CXCL9 and CXCL10 as required for migration of CD8 
memory T cells into IFRs, where they make contact with 
both antigen and APCs (Sung et al., 2012). Although the dis-
tinction between mIFRs and cIFRs was not made in these 
studies, it is clear that this chemoattractant is important in 
various conditions of immune response. In our study, formation 
of clusters of viral-specific CD4+ T cells with LNDCs was 
significantly reduced in CXCR3/ OT-II T cells. Because 
Using fluorescent reconstructions of full PLNs isolated at 
early time points after vaccination, we observed a major repo-
sitioning of LNDCs from the T cell cortex to the mIFR where 
they acquired viral antigen and became activated. This was 
unexpected because LNDCs are reported to be relatively ses-
sile at steady-state. The capture of virus by the resident DC was 
biologically relevant because they became positive for the che-
mokine CXCL10 and formed clusters with viral-specific CD4+ 
Figure 6. mDC-independent protection from influenza. (a) Confocal 
imaging of ALN follicles at day 10 after UV-PR8 vaccination in WT and vG 
mice. Dashed line: B cell follicle. Images are representative of two inde-
pendent trials; five mice/group. (b) ELISA analysis of PR8-specific serum 
antibodies at day 10 after UV-PR8 vaccination. Relative titers of PR8-
specific IgM, IgG1, and IgG2b are shown. Symbols represent individual 
animals. (c) Unvaccinated or vaccinated WT or vG groups were challenged 
with LD80 PR8 21 d after vaccination. Morbidity (left) and mortality 
(right) are displayed as percentage of body weight or percent survival, 
respectively. Red dashed line: morbidity/euthanasia experimental cutoff. 
Six mice/group. (d) ELISA analysis of PR8-specific serum antibodies at day 
9 after PR8 challenge as in c, compared with naive C57BL/6 littermates. 
Relative titers of PR8-specific IgM, IgG1, and IgG2b are shown. Symbols 
represent individual animals. *, P < 0.05; ***, P < 0.001. Mean ± SEM.
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cytometric identification. 1 or 5 × 106 cells were adoptively transferred into 
naive recipients for flow cytometric or imaging experiments, respectively.
Three-dimensional image analysis. Images were processed and 
analyzed using Volocity imaging software. Histocytometric analysis of 
reconstructions was performed with CellProfiler (Carpenter et al., 2006; 
Grigorova et al., 2010), and CellProfiler Analyst (Hickman et al., 2008; 
Jones et al., 2008; León et al., 2012). Analysis of reconstructions was per-
formed with individual XY imaging planes, which were representative of 
at least 400 µm of reconstructed LNs.
T cell clustering. CXCR3/ and WT OT-II cells were isolated as above, 
differentially labeled, and adoptively transferred into C57BL/6 recipients. 
PLNs were collected, processed, and serially imaged 24 h after vaccination 
with UV-PR8-OTII. T cell clusters were identified using a blinded approach, 
and the percentage of each population within these clusters was measured.
Ear resections. Ear removal was performed 30 min after injection of 10 µl 
PBS or UV-PR8 s.c. between the ear dermal layers. ELISA analysis of serum 
was performed through immobilization of UV-PR8 on the plate, addition of 
serum, and probing for specific binding of IgM, IgG1, or IgG2b.
Statistics. All statistics/graphical representations of collected data were as-
sembled through Prism (GraphPad Software). Mean and SEM are displayed 
where applicable. Results from Student’s t tests or Tukey’s post tests are indi-
cated by asterisks in the figures (*, P < 0.05; **, P < 0.005; ***, P < 0.001). 
One- or two-way ANOVA testing is indicated in the legends.
Online supplemental material. Video 1 shows LNDC migration in re-
sponse to influenza vaccination. Video 2 shows that LNDCs infiltrate the 
medulla after UV-PR8 vaccination. Video 3 shows reconstruction of a PLN. 
Video 4 shows lymph flow through the PLN. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20132327/DC1.
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